The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor.
Open accessAbstract
Apolipoprotein E (apoE) associates with lipoproteins and mediates their interaction with members of the LDL receptor family. ApoE exists as three common isoforms that have important distinct functional and biological properties. Two apoE isoforms, apoE3 and apoE4, are recognized by the LDL receptor, whereas apoE2 binds poorly to this receptor and is associated with type III hyperlipidemia. In addition, the apoE4 isoform is associated with the common late-onset familial and sporadic forms of Alzheimer's disease. Although the interaction of apoE with the LDL receptor is well characterized, the specificity of other members of this receptor family for apoE is poorly understood. In the current investigation, we have characterized the binding of apoE to the VLDL receptor and the LDL receptor-related protein (LRP). Our results indicate that like the LDL receptor, LRP prefers lipid-bound forms of apoE, but in contrast to the LDL receptor, both LRP and the VLDL receptor recognize all apoE isoforms. Interestingly, the VLDL receptor does not require the association of apoE with lipid for optimal recognition and avidly binds lipid-free apoE. It is likely that this receptor-dependent specificity for various apoE isoforms and for lipid-free versus lipid-bound forms of apoE is physiologically significant and is connected to distinct functions for these receptors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRP1 has little isoform-specific difference in its binding affinity to apoE3 and apoE4.
“LRP1 has little isoform-specific difference in its binding affinity to apoE3 and apoE4 (Kowal et al., 1990; Ruiz et al., 2005).”
From Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms (2014) · cites this paper as Ruiz et al., 2005
Compared with the other isoforms, apoE2 has only 1-2% of binding affinity to LDLR and its presence is associated with hyperlipidemia in some apoE2 individuals.
“Compared with the other isoforms, apoE2 has only 1–2% of binding affinity to LDLR and its presence is associated with hyperlipidemia in some apoE2 individuals (Ruiz et al., 2005).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Ruiz et al., 2005
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 62 · Cited by 204
- Authors
- Ruiz, J., Kouiavskaia, D., Migliorini, M., Robinson, S., Saenko, E. L., Gorlatova, N., Li, D., Lawrence, D., Hyman, B. T., Weisgraber, K. H., & Strickland, D. K.
- Affiliations
- Harvard University (US)
- Gladstone Institutes (US)
- Corresponding author
- Strickland, Dudley K.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 46
- Issue
- 8
- Pages
- 1721-1731
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2153350589
- Cited by
- 204
- References
- 62
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 12 · 2023: 12 · 2022: 21 · 2021: 11 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 6
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Aging (AG 12406)
- National Heart, Lung, and Blood Institute (HL72929, R01HL072929, HL50784, R01HL050784, P01HL041633, HL-54710, P01HL054710)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, APOE isoforms, VLDL receptor, LDL receptor-related protein, LDL receptor, receptor specificity, type III hyperlipidemia, Alzheimer's disease, lipoprotein binding
- MeSH terms
- Apolipoproteins E, Binding Sites, Cell Line, Cloning, Molecular, Humans, Peptide Fragments, Receptors, LDL, Surface Plasmon Resonance, Protein Interaction Mapping, Low Density Lipoprotein Receptor-Related Protein-1, Lipid Metabolism, Apolipoprotein E3, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review